GlassScriptPhysician profile
David Kingsley
NPI 1366452344
$1,299.70
in general payments reported to CMS, 2019-2025
11 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $114 · 2021: $305 · 2022: $252 · 2023: $293 · 2024: $106 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $503.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $769.59 | 2019-2025 | |
| Janssen Biotech, INC. | $111.21 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $101.83 | 2023-2024 | Sotyktu |
| Lilly USA, LLC | $52.38 | 2022-2023 | Taltz, Olumiant |
| Mallinckrodt Hospital Products INC. | $49.20 | 2025 | Acthar |
| Sun Pharmaceutical Industries INC. | $47.63 | 2021-2022 | |
| Dermira, INC. | $46.07 | 2019 | |
| Leo Pharma INC. | $39.22 | 2023 | Adbry |
| Regeneron Healthcare Solutions, INC. | $34.31 | 2019 | |
| Genentech USA, INC. | $32.12 | 2023-2024 | Erivedge |
| Organon LLC | $16.14 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kingsley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.